Dr. Kris Explains the Use of Gene Signatures

Mark G. Kris, MD
Published: Monday, Jul 25, 2011

Mark G. Kris, MD, chief of the Thoracic Oncology Service at Memorial Sloan-Kettering Cancer Center, explains the gene signature process which involves testing for the expression of multiple genes and associating the overexpression of these genes with a clinical outcome. He describes gene signatures as a risk stratification system that arranges patients according to their gene signatures.
Mark G. Kris, MD, chief of the Thoracic Oncology Service at Memorial Sloan-Kettering Cancer Center, explains the gene signature process which involves testing for the expression of multiple genes and associating the overexpression of these genes with a clinical outcome. He describes gene signatures as a risk stratification system that arranges patients according to their gene signatures.

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
34th Annual Miami Breast Cancer Conference® Clinical Case Vignette Series™May 25, 20182.0
Community Practice Connections™: CDK4/6 Inhibitors With the Experts: The Role of Emerging Agents for the Management of Metastatic Breast CancerMay 30, 20182.0
Publication Bottom Border
Border Publication
x